9 days ago
ARQT
AnalystsSeamus FernandezSeamus Fernandez's Stock Forecasts
AnalystsSeamus Fernandez
Analyst Ranking
Top 2%
#75 out of 5549 analysts
Average Return
+56.21%
Win Rate
63%74 out of 117
Risk vs Reward
Poor
Good
Seamus Fernandez's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cidara Therapeutics IncCDTX | +1,088.30% | $18.63 | $221.38 | 2025-05-09 - 2026-01-06 | Strong Buy |
Cidara Therapeutics IncCDTX | +768.16% | $25.50 | $221.38 | 2025-05-16 - 2026-01-06 | Strong Buy |
Cidara Therapeutics IncCDTX | +673.26% | $13.50 | $104.39 | 2024-11-08 - 2025-11-07 | Strong Buy |
Mbx Biosciences IncMBX | +424.08% | $6.27 | $32.86 | 2025-04-10 - 2026-04-09 | Strong Buy |
Cidara Therapeutics IncCDTX | +372.63% | $46.84 | $221.38 | 2025-06-24 - 2026-01-06 | Strong Buy |
Seamus Fernandez Analyst Color
Get additional color on Seamus Fernandez's coverage of popular stocks
23 days ago
PCVX
a month ago
MBX
a month ago
LLY
a month ago
IVA
2 months ago
AMLX
2 months ago
AMLX
3 months ago
SEPN
3 months ago
ARQT
3 months ago
BMY
4 months ago
AMLX
4 months ago
TENX
6 months ago
LLY
7 months ago
LLY
7 months ago
APGE
7 months ago
AMLX
7 months ago
TENX
8 months ago
RYTM
9 months ago
LLY
9 months ago
GPCR
9 months ago
MBX
10 months ago
TENX
10 months ago
RYTM
a year ago
BMY
a year ago
LLY
Seamus Fernandez's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arcutis Biotherapeutics IncARQT | 6 | Strong Buy | $44.00 | +38.89% | Maintains | 9 days ago |
Vaxcyte IncPCVX | 6 | Strong Buy | $125.00 | +106.03% | Maintains | 23 days ago |
Sagimet Biosciences IncSGMT | 3 | Strong Buy | $26.00 | +149.52% | Maintains | a month ago |
Mbx Biosciences IncMBX | 6 | Strong Buy | $150.00 | +183.18% | Maintains | a month ago |
Eli Lilly & CoLLY | 19 | Strong Buy | $1,284.00 | +0.16% | Maintains | a month ago |
Inventiva SaIVA | 2 | Strong Buy | $14.00 | +279.92% | Maintains | a month ago |
Tenax Therapeutics IncTENX | 7 | Hold | N/A | N/A | Downgrades | 2 months ago |
Amylyx Pharmaceuticals IncAMLX | 6 | Strong Buy | $57.00 | +101.41% | Maintains | 2 months ago |
Septerna IncSEPN | 2 | Strong Buy | $51.00 | +15.54% | Maintains | 3 months ago |
Bristol Myers Squibb CoBMY | 9 | Strong Buy | $75.00 | +21.85% | Maintains | 3 months ago |
Apogee Therapeutics IncAPGE | 10 | Hold | N/A | N/A | Downgrades | 4 months ago |
Avalyn Pharma IncAVLN | 1 | Strong Buy | $80.00 | +209.72% | Initiates Coverage On | 5 months ago |
Aclaris Therapeutics IncACRS | 2 | Strong Buy | $12.00 | +216.62% | Initiates Coverage On | 6 months ago |
Generate Biomedicines IncGENB | 1 | Strong Buy | $30.00 | +127.10% | Initiates Coverage On | 7 months ago |
Rhythm Pharmaceuticals IncRYTM | 4 | Strong Buy | $143.00 | +55.13% | Maintains | 8 months ago |
Structure Therapeutics IncGPCR | 3 | Strong Buy | $140.00 | +549.65% | Maintains | 9 months ago |
SanofiSNY | 1 | Hold | N/A | N/A | Downgrades | a year ago |
Cidara Therapeutics IncCDTX | 6 | Hold | N/A | N/A | Downgrades | a year ago |
Arcturus Therapeutics Holdings IncARCT | 4 | Hold | N/A | N/A | Downgrades | a year ago |
Verve Therapeutics IncVERV | 2 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Metsera IncMTSR | 1 | Strong Buy | $56.00 | N/A | Initiates Coverage On | 2 years ago |
Mineralys Therapeutics IncMLYS | 2 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Merck & Co IncMRK | 9 | Strong Buy | $122.00 | N/A | Maintains | 2 years ago |
Gsk PLCGSK | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Revance Therapeutics IncRVNC | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Hillevax IncHLVX | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Altimmune IncALT | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Icosavax IncICVX | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Cymabay Therapeutics IncCBAY | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 3 years ago |
Albireo Pharma IncALBO | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Dice Therapeutics IncDICE2 | 1 | Strong Buy | $65.00 | N/A | Initiates Coverage On | 4 years ago |
Novo Nordisk A SNVO | 2 | Strong Buy | N/A | N/A | Upgrades | 4 years ago |
Invivyd IncIVVD | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Novartis AgNVS | 3 | Hold | N/A | N/A | Downgrades | 7 years ago |
Dermira IncDERM2 | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Tesaro IncTSRO | 4 | Hold | $75.00 | N/A | Downgrades | 8 years ago |
Intra Cellular Therapies IncITCI | 3 | Buy | $27.00 | N/A | Initiates Coverage On | 8 years ago |
Allergan PLCAGN | 3 | Buy | $220.00 | N/A | Initiates Coverage On | 8 years ago |
Celldex Therapeutics IncCLDX | 2 | Hold | $45.00 | N/A | Maintains | 9 years ago |
Astrazeneca PLCAZN | 3 | Hold | $38.00 | N/A | Maintains | 9 years ago |
Pfizer IncPFE | 1 | Hold | $38.00 | N/A | Maintains | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.